Abstract: A process for treating adult respiratory distress syndrome by the systemic administration of ibuprofen (p-isobutylhydratropic acid) or a salt or ester thereof. Dosage forms are also disclosed.
Abstract: A process for treating the blood-brain barrier by the systemic administration of ibuprofen (p-isobutylhydratropic acid) or a salt or ester thereof. Dosage forms are also disclosed.
Abstract: Aluminum ibuprofen pharmaceutical liquid suspensions having improved resistance to dissolution rate reduction upon storage containing aluminum ibuprofen, a suspending agent have a particle size below 50 microns, a water-soluble surface active agent, water, and preferably also from 5 to 30 grams of sucrose per 100 ml of suspension are disclosed, or its sweetening equivalent of glucose, fructose, sodium saccharin sodium cyclamate, or mixtures thereof.
Type:
Grant
Filed:
May 11, 1981
Date of Patent:
November 30, 1982
Assignee:
The Upjohn Manufacturing Company
Inventors:
Susanne M. Peck, Lois J. Larion, Englebert L. Rowe
Abstract: A process for preventing a reducing adhesion formation by the systemic administration of ibuprofen (p-isobutylhydratropic acid) or a salt or ester thereof. Dosage forms are also desirable.
Abstract: Microbiological process for preparing the antibiotic lincomycin at temperatures ranging from 18.degree. C. to 45.degree. C. using the newly discovered microorganism Streptomyces vellosus. The subject process advantageously results in the preparation of lincomycin without the concomitant production of lincomycin B (4'-depropyl-4'-ethyllincomycin). The absence of lincomycin B production results in increased lincomycin recovery efficiency.
Type:
Grant
Filed:
June 10, 1974
Date of Patent:
June 2, 1981
Assignee:
The Upjohn Manufacturing Company
Inventors:
Malcolm E. Bergy, John H. Coats, Vedpal S. Malik